Example: Heart Attack

Search clinical trials for: Antiparasitic Agents

Total 2814 results

    • NCT01445938
      Terminated
      Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria
      Conditions: Malaria
    • NCT03598842
      Enrolling by invitation
      Tuberculosis - Learning the Impact of Nutrition
      Conditions: Tuberculosis; Malnutrition; Helminth Infection
    • NCT02841215
      Recruiting
      Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies
      Conditions: Gale; Severe Forms of Scabies; Oral Parasitic Drug; Ivermectin
    • NCT03553615
      Withdrawn
      Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis
      Conditions: Atopic Dermatitis
    • NCT03605758
      Recruiting
      Treatment of Strongyloides Infection
      Conditions: Strongyloides Stercoralis Infection; Strongyloidiasis
    • NCT01070277
      Unknown status
      Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea
      Conditions: Chronic Diarrhea; Abdominal Pain; Bloating
    • NCT00441285
      Completed
      Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
      Conditions: Neurocysticercosis; Epilepsy
    • NCT03474276
      Completed
      Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old
      Conditions: Moderate Acute Malnutrition
    • NCT00002158
      Unknown status
      A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
      Conditions: Cryptosporidiosis; HIV Infections
    • NCT04463264
      Recruiting
      Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
      Conditions: COVID-19
    • NCT02234570
      Completed
      Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
      Conditions: Neurocysticercosis
    • NCT03950037
      Not yet recruiting
      SANCC: Clinical Trial Early Intervention
      Conditions: Subarachnoid Neurocysticercosis
    • NCT02046200
      Completed
      Development of Ivermectin for Alcohol Use Disorders
      Conditions: Alcohol Use Disorder
    • NCT03578679
      Completed
      Treatment of Pediculosis (Head Lice) in Senegal
      Conditions: Pediculoses
    • NCT04405843
      Active, not recruiting
      Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)
      Conditions: COVID-19
    • NCT03967054
      Recruiting
      Repeat Ivermectin Mass Drug Administrations for MALaria Control II
      Conditions: Malaria
    • NCT04429711
      Recruiting
      Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19
      Conditions: COVID-19
    • NCT03177993
      Completed
      Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji
      Conditions: Lymphatic Filariases; Scabies; Impetigo; Soil Transmitted Helminths
    • NCT03257943
      Completed
      A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%
      Conditions: Lice; Head Lice
    • NCT03301649
      Completed
      Clinical Endpoint Study of Ivermectin 0.5% Lotion
      Conditions: Head Lice
    • NCT03052998
      Completed
      Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy
      Conditions: Ivermectin; Onchocerciasis; Epilepsy
    • NCT04635943
      Recruiting
      Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19
      Conditions: Covid19; Coronavirus Infection; SARS-CoV Infection
    • NCT04523090
      Recruiting
      Catalysing the Containment of COVID-19
      Conditions: Covid19
    • NCT03517462
      Completed
      Ocular Changes After Ivermectin - (DOLF IVM/Oncho)
      Conditions: Onchocerciasis
    • NCT04602507
      Not yet recruiting
      Ivermectin in Adults With Severe COVID-19.
      Conditions: Covid19; Severe Acute Respiratory Syndrome
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations